Cargando…
Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
Contrast‐enhanced MRI (CE‐MRI) is the most sensitive technique for breast cancer detection. Contrast‐enhanced mammography (CEM) is emerging as a possible alternative to CE‐MRI. PURPOSE: To evaluate the diagnostic performance of a low radiation dose contrast‐enhanced mammography (L‐CEM) in women with...
Autores principales: | Clauser, Paola, Baltzer, Pascal A.T., Kapetas, Panagiotis, Hoernig, Mathias, Weber, Michael, Leone, Federica, Bernathova, Maria, Helbich, Thomas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496227/ https://www.ncbi.nlm.nih.gov/pubmed/32061002 http://dx.doi.org/10.1002/jmri.27079 |
Ejemplares similares
-
Is the Level of Contrast Enhancement on Contrast-Enhanced Mammography (CEM) Associated with the Presence and Biological Aggressiveness of Breast Cancer?
por: Marzogi, Alaa, et al.
Publicado: (2023) -
Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis
por: Fueger, Barbara J., et al.
Publicado: (2021) -
One view or two views for wide-angle tomosynthesis with synthetic mammography in the assessment setting?
por: Clauser, Paola, et al.
Publicado: (2021) -
The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams
por: Milos, Ruxandra Iulia, et al.
Publicado: (2020) -
Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)